Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.

Heart Protection Study Collaborative Group (2005) Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals. Lancet, 365 (9473). pp. 1779-1780. ISSN 1474-547X

Full text not available from this repository.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:13
Last Modified:	03 Nov 2022 15:32
URI:	https://ueaeprints.uea.ac.uk/id/eprint/15416
DOI:	10.1016/S0140-6736(05)63014-0

Actions (login required)

View Item